X4 Pharmaceuticals, Inc - COM (XFOR)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
101M
Holdings value Q3 2024
$67.3M
Value change Q3 2024
-$551K
Grand Portfolio weight change Q3 2024
0%
Number of holders
98
Number of buys Q3 2024
44
Number of sells Q3 2024
-28
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 101M $67.3M -$551K $0.67 99
2024 Q2 102M $58.9M -$4.47M $0.58 98
2024 Q1 103M $143M +$10.3M $1.39 97
2023 Q4 96.8M $81.2M -$18.7M $0.84 91
2023 Q3 112M $123M -$3.81M $1.09 90
2023 Q2 113M $219M +$104M $1.94 97
2023 Q1 61M $53M +$698K $0.87 55
2022 Q4 60.6M $60.2M +$20.6M $0.99 52
2022 Q3 39.1M $66.8M +$39.5M $1.71 53
2022 Q2 16M $15.5M -$681K $0.97 43
2022 Q1 16.3M $28.6M -$2.24M $1.75 52
2021 Q4 17.6M $40.2M -$2.29M $2.29 50
2021 Q3 16.2M $85.7M -$2.86M $5.29 48
2021 Q2 16.6M $108M +$972K $6.50 58
2021 Q1 16.1M $139M +$48.9M $8.61 59
2020 Q4 10.5M $67.4M +$1.56M $6.43 53
2020 Q3 10.2M $69.3M -$5.28M $6.77 50
2020 Q2 10.7M $99.7M -$2.35M $9.32 54
2020 Q1 11.3M $113M +$1.38M $10.00 49
2019 Q4 11M $118M +$34.8M $10.70 53
2019 Q3 7.74M $98.4M +$1.73M $12.71 50
2019 Q2 7.59M $114M +$87.1M $15.00 44
2019 Q1 1.79M $31.1M +$31.1M $17.41 29